Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
John P. Gandolfo | Director | 2025-05-23 | 1,800 | $5.01 | $9.02kBuy |
Thomas J. Errico | Director | 2025-05-12 | 10,000 | $4.77 | $47.74kBuy |
Thomas J. Errico | Director | 2025-03-17 | 6,000 | $8.10 | $48.59kBuy |
Daniel S. Goldberger | Chief Executive Officer | 2025-03-17 | 1,000 | $8.59 | $8.59kBuy |
Thomas J. Errico | Director | 2024-08-15 | 5,000 | $6.12 | $30.60kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Joseph P. Errico | 52.04% | 3,861,942 | $21.05M | Insider |
Merck Global Health Innovation Fund LLC | 45.09% | 3,346,032 | $18.24M | Insider |
James L. L. Tullis | 27.14% | 2,014,110 | $10.98M | Insider |
Thomas J. Errico | 13.09% | 971,491 | $5.29M | Insider |
Core Ventures II LLC | 8.71% | 646,342 | $3.52M | Insider |
Peter S. Staats | 6.42% | 476,419 | $2.60M | Insider |
Charles Steve Theofilos | 6.24% | 462,758 | $2.52M | Insider |
Francis R. Amato | 4.96% | 368,355 | $2.01M | Insider |
Awm Investment Company Inc | 4.29% | 318,106 | $1.73M | Institution |
Daniel S. Goldberger | 3.92% | 290,565 | $1.58M | Insider |